Glycemic Control in the Hospitalized Patient: An Advanced Practice Nurse (APN) Evidence-Based Practice Project

M., Hodges; M., Campbell; M., Boocher; M., Dinsmore; E., Greene; A., Hill; M., Peterangelo; D., Ruxer; K., Sadlier; M. J., Trout
April 2008
Critical Care Nurse;Apr2008, Vol. 28 Issue 2, pe31
Academic Journal
An abstract of the study "Glycemic Control in the Hospitalized Patient: An Advanced Practice Nurse (APN) Evidence-Based Practice Project," by M. Hodges, M. Campbell, M. Boocher, M. Dinsmore, E. Greene, A. Hill, M. Peterangelo, D. Ruxer, K. Sadlier and M. J. Trout is presented.


Related Articles

  • A patient with recalcitrant hyperglycemia. Singh, Inderpal // Patient Care;1/15/1996, Vol. 30 Issue 1, p167 

    Focuses on a case of a woman with recalcitrant hyperglycemia. Profile of the patient; Condition of the woman; Medication; Types of insulin resistance.

  • Case Study: Atypical Antipsychotic Use Associated With Severe Hyperglycemia. McNeely, Marguerite J. // Clinical Diabetes;Fall2002, Vol. 20 Issue 4, p195 

    Focuses on the treatment of a patient with severe hyperglycemia. Symptoms of the illness; Measurement of glucose levels; Risks of diabetes.

  • Pharmacologic therapy for type 2 diabetes mellitus. DeFronzo, Ralph A. // Annals of Internal Medicine;08/17/99, Vol. 131 Issue 4, p281 

    Examines the goals of antihyperglycemic therapy in type 2 diabetes mellitus as well as the mechanism of action, efficacy and safety profiles of the five approved classes of oral agents. Therapeutic algorithm for the initiation of oral therapy; Comparison of sulfonylureas, repaglinide,...

  • sulfonylurea.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2237 

    A definition of the term "sulfonylurea," which refers to a class of oral drugs that is used in controlling hyperglycemia in type 2 diabetes mellitus, is presented.

  • Low-Dosage Continuous Insulin Infusion for Diabetic Coma. Molnar, G.D.; Service, F.J. // Annals of Internal Medicine;Dec74, Vol. 81 Issue 6, p853 

    Editorial. Comments on the studies conducted to determine the effectiveness of low dosage continuous insulin infusion for the treatment of severe hyperglycemia. Details of the studies; Principle behind the method; Advantages of the procedure.

  • Treatment of Hyperglycemia in a 7-Year-Old Child Diagnosed With Neonatal Diabetes. Hathout, Eba; Mace, John; Bell, Graeme I.; Njølstad, Pål R. // Diabetes Care;Jun2006, Vol. 29 Issue 6, p1458 

    A letter to the editor about the treatment of hyperglycemia in a child diagnosed with neonatal diabetes is presented.

  • Management of the Hyperosmolar Hyperglycemic Syndrome. Matz, Robert // American Family Physician;10/1/1999, Vol. 60 Issue 5, p1468 

    Reveals steps in the treatment of hyperosmolar hyperglycemic syndrome. Signs and symptoms; Clinical spectrum of severe hyperglycemic disorders; Pathogenesis; Clinical manifestations; Treatment; Complications.

  • Insufficient evidence for antihypergycaemics/cancer link.  // Reactions Weekly;8/31/2013, Issue 1467, p2 

    The article focuses on a joint consensus statement from the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE), which found that a link between the use of antihyperglycaemics and the risk of developing cancer could not be proved due to...

  • Farewell to Phenformin for Treating Diabetes Mellitus. Williams, Robert H. // Annals of Internal Medicine;Oct75, Vol. 83 Issue 4, p567 

    Editorial. Discusses phenformin which causes slight reduction of hyperglycemia. Information on a study conducted by the University Group Diabetes Program regarding the chronic toxic effects of phenformin; Comparison between phenformin treatment and placebo plus insulin treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics